= Additional active ingredients
PRESENTATION AND DOSSAGE
TABS: 30 X 5 mg
TABS: 30 X 10 mg
TABS: 30 X 20 mg
NO INTERACTION WITH FOOD
Treatment of essential hypertension, renovascular hypertension, congestive heart failure, and to reduce mortality in patients with all degrees of heart failure. To retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.
Hypersensitivity to enalapril, to any of the excipients or any other ACE inhibitor. Children and infants with impaired kidney function, hereditary or idiopathic angioedema. Second and third trimesters of pregnancy. See literature.
Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported. Excessive hypotension, patients with ischemic heart or cerebrovascular disease. Periodic monitoring of white blood cell counts in patients with collagen vascular disease and renal disease should be considered. Lactation, pediatrics, impaired renal function, hyperkalemia, surgery/anesthesia, cough. See prescribing information for full details.
Adverse experiences were mild and transient in nature. In clinical trials, discontinuation of therapy due to clinical adverse experiences was required in 3.3% of patients with hypertension, and in 5.7% of patients with heart failure. Fatigue, orthostatic effects, asthenia, diarrhea, nausea, headache, dizziness, cough, rash. See prescribing information for full details.
See prescribing information for full details.
PREGNANCY & LACTATION
MANUFACTURER & DISTRIBUTER:
Manufacturer: Dexcel Ltd.